Prazepam adverse event reports that FDA received

Name: Reaction terms in FDA adverse event reports that name Prazepam
Creator: Reported Reactions
License: https://creativecommons.org/publicdomain/zero/1.0/

Name type: Product name as reported

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Drug reports received through 30 Jun 2026. Device reports have a separate cutoff, 30 Sep 2026. Why a report count is not a rate.

Reports on file

From July 2004 to June 2026, FDA received 1,556 adverse event reports that name Prazepam. The name is as reporters wrote it. In these reports the drug is a suspect or interacting product.

In the same period, 1,322 further reports name it only as a concomitant medicine. The counts on this page do not include these reports.

FDA received 159 reports in the 12 months to June 2026 and 141 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 159 (under 0.1%) name Prazepam. Reports from consumers or other non-health professionals were 8.9% of the reports that name Prazepam and 45.8% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate. A count of reports is not a count of events or of patients, because one event can have more than one report.

There are many instances of duplicative reports and some reports do not contain all the necessary information.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Suspect product

FDA records each drug in a report as suspect, concomitant or interacting. This page counts the reports in which Prazepam is suspect or interacting. FDA says:

Any number of the drugs may be marked as suspect if thought to be responsible for one or more of the reactions, but that information is not validated.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Since the last update

FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The information in these reports cannot be used to estimate the incidence (occurrence rates) of the events reported.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

The latest update of the FDA data, recorded on 28 Oct 2026, changed no count of this page.

In April to June 2026, FDA received 48 reports that name Prazepam.
In January to March 2026, FDA received 39.
In April to June 2025, FDA received 34.

April to June 2026 is the latest closed quarter in the data. A closed quarter is a quarter for which the FDA files have most of the reports.

All updates Feed of updates (RSS)

Reaction lookup

These are the reaction terms that the reports record, with the number of reports for each term. Type a term or a plain word to find its count.

What this list leaves out

The table lists the 292 reaction terms that 5 or more reports record. A term with fewer than 5 reports is not in the table.

The site keeps reaction terms for 1,496 of the 1,556 reports (96.1%).

The reports of the other years are not in the counts.

So a count in the table can be lower than the count of FDA.

Find a reaction term

The table shows the first 50 of 292 terms.

Reaction terms in the reports that name Prazepam, most reports first
Reaction term (MedDRA) and plain meaning	Reports	Share of the 1,556 reports
Coma	264	17%
Somnolencedrowsiness	223	14.3%
Poisoning deliberate	191	12.3%
Toxicity to various agentspoisoning or toxic effect of one or more substances	160	10.3%
Drug abusemisuse of a medicine	158	10.2%
Hypotensionlow blood pressure	122	7.8%
Confusional stateconfusion	101	6.5%
Altered state of consciousness	83	5.3%
Intentional overdosea deliberate overdose	76	4.9%
Overdosea dose above the recommended amount	73	4.7%
Drug use disorder	72	4.6%
Drug dependencedependence on a medicine	71	4.6%
Suicide attempta suicide attempt	68	4.4%
Miosis	54	3.5%
Intentional product misusedeliberate use not as intended	52	3.3%
Respiratory depressionslow or shallow breathing	52	3.3%
Falla fall	51	3.3%
Vomitingbeing sick	51	3.3%
Tachycardiafast heart rate	50	3.2%
Bradycardiaslow heart rate	48	3.1%
Loss of consciousnesspassing out	46	3%
Condition aggravatedthe condition being treated got worse	45	2.9%
Pneumonia aspirationlung infection from breathing in material	43	2.8%
Substance use disorder	43	2.8%
Electrocardiogram QT prolongeda QT prolongation on the ECG	41	2.6%
Mydriasis	39	2.5%
Disturbance in attentiondifficulty concentrating	37	2.4%
Hepatic cytolysis	37	2.4%
Hypotonia	36	2.3%
Disorientation	35	2.2%
Encephalopathy	35	2.2%
Thrombocytopenialow platelets	35	2.2%
Speech disordera speech problem	31	2%
Aggressionaggressive behaviour	30	1.9%
Cerebral haemorrhage	30	1.9%
Agitationrestlessness	29	1.9%
Bladder dilatation	29	1.9%
Cardiomyopathydisease of the heart muscle	28	1.8%
Hypothermia	28	1.8%
Myocarditisinflammation of the heart muscle	28	1.8%
Accidental poisoning	27	1.7%
Hepatitis acute	27	1.7%
Labelled drug-drug interaction issue	27	1.7%
Myocardial infarctionheart attack	27	1.7%
Amnesiamemory loss	26	1.7%
Respiratory failurethe lungs could not supply enough oxygen	26	1.7%
Anxiety	25	1.6%
Drug interactionan interaction between medicines	25	1.6%
Victim of crime	25	1.6%
Aspirationbreathing material into the lungs	24	1.5%

Download all 292 terms of Prazepam (CSV)

The counts add to more than 1,556 reports, because one report can record more than one term. FDA says:

No individual drug is connected to any individual reaction. When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The CSV file has the same rows and the same limits. Its last row is a note that says so.

MedDRA term

The person who codes a report selects the preferred term that agrees best with the description of the reporter. The words under a term are the plain meaning that this site gives.

Not the label

The FDA-approved label of a product lists its adverse reactions. See the official pages at the end of this page.

Outcomes by year

The table gives the outcomes that the reporters gave, in the terms of FDA.

Outcomes in the reports that name Prazepam, by the year of the openFDA file that holds the report

The table continues to the right.

Year of the openFDA file	Reports	Serious	Death	Life-threatening	Hospitalization (initial or prolonged)	Disability or Permanent Damage	Congenital Anomaly/Birth Defect	Other Serious (Important Medical Events)	Not serious
2004	6	6	0	1	6	0	0	0	0
2005	10	10	3	0	5	1	0	3	0
2006	16	16	1	0	12	1	1	3	0
2007	2	2	0	0	2	0	0	0	0
2008	11	11	3	2	10	0	1	3	0
2009	23	23	2	3	18	0	2	5	0
2010	7	7	1	0	2	1	0	3	0
2011	35	35	3	4	22	0	3	11	0
2012	31	31	3	6	19	0	3	14	0
2013	11	11	0	2	9	0	0	1	0
2014	4	4	0	2	4	0	0	2	0
2015	15	15	1	4	12	0	0	5	0
2016	9	9	1	1	6	0	2	3	0
2017	24	24	1	0	21	1	0	6	0
2018	135	135	5	27	77	0	0	51	0
2019	170	168	12	8	121	1	1	56	2
2020	179	178	11	2	110	16	0	62	1
2021	141	141	13	23	62	6	7	87	0
2022	136	135	7	15	65	6	0	78	1
2023	182	182	31	30	89	0	0	78	0
2024	140	140	23	41	84	5	0	59	0
2025	176	176	23	49	108	0	1	106	0
2026	93	92	6	26	32	4	0	51	1

An outcome in a report is not proof that the drug was the cause. The reporter gives the outcome, and FDA does not verify it. FDA says:

The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The six headings with the names of FDA are the outcome terms of FDA. A report can have more than one outcome. The columns Serious and Not serious are the two values of the openFDA field serious. For the value serious, openFDA gives this description:

The adverse event resulted in death, a life threatening condition, hospitalization, disability, congenital anomaly, or other serious condition
Source: openFDA, Drug adverse event fields (YAML reference). The site read the page on 2 Oct 2026.

The year is the year of the openFDA file that holds the latest version of the report. It is not always the year in which FDA first received the report. The chart of the next section uses the year of first receipt. The latest year is not complete.

Reports by year and month

Reports that name Prazepam, by the year in which FDA received them

The column of 2026 has an outline, because the year is not complete. It has the reports that FDA received through June 2026 only.

Show the figures of the chart as a table

Reports that name Prazepam, by the year in which FDA received them
Year	Reports
2004	6
2005	9
2006	14
2007	5
2008	11
2009	22
2010	7
2011	32
2012	36
2013	11
2014	5
2015	17
2016	11
2017	29
2018	147
2019	172
2020	186
2021	144
2022	146
2023	164
2024	140
2025	155
2026	87

Reports that name Prazepam, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Why a count moves

A count moves for many reasons. The guide gives FDA's words about them.

Patients and reporters

Age of the patient in the reports that name Prazepam
Age	Reports	Share
Under 2	21	1.3%
2 to 11	6	0.4%
12 to 17	69	4.4%
18 to 44	486	31.2%
45 to 64	452	29%
65 to 74	137	8.8%
75 and over	145	9.3%
Age not given	240	15.4%

Sex of the patient in the reports that name Prazepam
Sex	Reports	Share
Female	890	57.2%
Male	526	33.8%
Unknown or not given	140	9%

Type of reporter in the reports that name Prazepam
Reporter	Reports	Share
Physician	639	41.1%
Pharmacist	426	27.4%
Other health professional	324	20.8%
Lawyer	2	0.1%
Consumer or non-health professional	138	8.9%
Not given	27	1.7%

Age and sex are as the report gives them. The reporter is the primary source in the report. 0.6% of the reports give the United States as the country.

Reason for use

Reason for use (indication) that the reports of Prazepam record
Indication as recorded (MedDRA)	Reports	Share
Anxiety	203	13%
Depression	77	4.9%
Toxicity to various agents	62	4%
Poisoning deliberate	56	3.6%
Suicide attempt	39	2.5%
Intentional overdose	32	2.1%

The reporter fills in the indication, and the field is often empty. Each share is of all 1,556 reports.

Drugs in the same reports

Other drugs that the reports of Prazepam name, in any role, in order of name
Drug	Reports that name the two
Acetaminophen	141
Alprazolam	161
Cocaine	106
Diazepam	117
Mirtazapine	121
Oxazepam	107
Paroxetine	169
Quetiapine	144
Venlafaxine	148
Zopiclone	231

The table has the 10 drug names that these reports name most. Two names in one report says only that the report recorded the two. It says nothing about the part of a product in the event.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pages near this one

Prazaxa next in the A to Z list
Prazosin next in the A to Z list
Praxbind next in the A to Z list
Prazosin hcl next in the A to Z list
Pravastatin sodium next in the A to Z list
Prazosin hydrochloride next in the A to Z list
Pravastatin next in the A to Z list
Precedex next in the A to Z list
Pravachol next in the A to Z list
Pred Forte next in the A to Z list
Prasugrel hydrochloride next in the A to Z list
Prednisolon next in the A to Z list

These links are for navigation. No count selected them.

Official pages

DailyMed labels for PrazepamThe labels (prescribing information) that have this name, at the National Library of Medicine.
MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Prazepam: adverse event reports that FDA received. https://reportedreactions.com/drug/prazepam/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

A report is in the count when it names Prazepam as a suspect or interacting product. The 1,322 reports that name it only as a concomitant medicine are not in the count. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Do these reports show that Prazepam was responsible for the reactions?

No. FDA says:

For any given report, there is no certainty that a suspected drug caused the event.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

A reaction can relate to the condition that the drug treats, to other medicines, or to something else.

Is this the list of reactions on the label of Prazepam?

No. It is a count of what people reported to FDA: 1,556 reports from July 2004 to June 2026. The FDA-approved label of a product lists its adverse reactions. The official pages at the end of this page link to the labels.

Who sent these reports?

Physician (41.1%), pharmacist (27.4%) and other health professional (20.8%). These are the types of reporter for the reports that name this drug.

If a manufacturer receives an adverse event report, it is normally required to send the report to FDA.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.

To the top of the page